ReP USP - Resultado da busca

Artigo de periodico
The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction (2023)
Ferezin, Letícia Perticarrara; Cotta Filho, Cezar Kayzuka ; Pereira, Vitória Carolina Rondon; Andrade, Murilo Ferreira de; Molina, Carlos Augusto Fernandes ; Tucci Júnior, Silvio ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: Life. Unidades: FMRP, EERP
Assuntos: DISFUNÇÃO ERÉTIL, POLIMORFISMO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEREZIN, Letícia Perticarrara et al. The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction. Life, v. 13, n. 5, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.3390/life13051082. Acesso em: 14 nov. 2024.
APA
Ferezin, L. P., Cotta Filho, C. K., Pereira, V. C. R., Andrade, M. F. de, Molina, C. A. F., Tucci Júnior, S., et al. (2023). The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction. Life, 13( 5), 1-13. doi:10.3390/life13051082
NLM
Ferezin LP, Cotta Filho CK, Pereira VCR, Andrade MF de, Molina CAF, Tucci Júnior S, Tanus-Santos JE, Lacchini R. The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction [Internet]. Life. 2023 ; 13( 5): 1-13.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/life13051082
Vancouver
Ferezin LP, Cotta Filho CK, Pereira VCR, Andrade MF de, Molina CAF, Tucci Júnior S, Tanus-Santos JE, Lacchini R. The rs2682826 polymorphism of the NOS1 gene is associated with the degree of disability of erectile dysfunction [Internet]. Life. 2023 ; 13( 5): 1-13.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/life13051082
Artigo de periodico
The association of biochemical and genetic biomarkers in VEGF pathway with depression (2022)
Nunes, Fernanda Daniela Dornelas; Ferezin, Letícia Perticarrara; Pereira, Sherliane Carla ; Figaro-Drumond, Fernanda Viana; Pinheiro, Lucas Cezar ; Menezes, Itiana Castro; Baes, Cristiane Von Werne ; Coeli-Lacchini, Fernanda Borchers ; Tanus-Santos, José Eduardo ; Juruena, Mario Francisco; Lacchini, Riccardo
Fonte: Pharmaceutics. Unidades: EERP, FMRP
Assuntos: DEPRESSÃO, COMPORTAMENTO DE RISCO, SUICIDAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Fernanda Daniela Dornelas et al. The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, v. 14, n. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122757. Acesso em: 14 nov. 2024.
APA
Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., Figaro-Drumond, F. V., Pinheiro, L. C., Menezes, I. C., et al. (2022). The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, 14( 12), 1-15. doi:10.3390/pharmaceutics14122757
NLM
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/pharmaceutics14122757
Vancouver
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/pharmaceutics14122757
Artigo de periodico
TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels (2022)
Melo, Isabela Borges de; Oliveira-Paula, Gustavo Henrique; Ferezin, Letícia Perticarrara; Ferreira, Graziele Cristina ; Pinheiro, Lucas Cezar ; Tanus-Santos, José Eduardo ; Garcia, Luis Vicente ; Lacchini, Riccardo ; Garcia, Waynice Neiva de Paula
Fonte: Current Issues in Molecular Biology. Unidades: FMRP, EERP
Assuntos: MEDICAMENTO, PRESSÃO SANGUÍNEA, POLIMORFISMO, ÓXIDO NÍTRICO, ANESTÉSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Isabela Borges de et al. TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels. Current Issues in Molecular Biology, v. 44, n. 12, p. 6333-6345, 2022Tradução . . Disponível em: https://doi.org/10.3390/cimb44120432. Acesso em: 14 nov. 2024.
APA
Melo, I. B. de, Oliveira-Paula, G. H., Ferezin, L. P., Ferreira, G. C., Pinheiro, L. C., Tanus-Santos, J. E., et al. (2022). TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels. Current Issues in Molecular Biology, 44( 12), 6333-6345. doi:10.3390/cimb44120432
NLM
Melo IB de, Oliveira-Paula GH, Ferezin LP, Ferreira GC, Pinheiro LC, Tanus-Santos JE, Garcia LV, Lacchini R, Garcia WN de P. TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels [Internet]. Current Issues in Molecular Biology. 2022 ; 44( 12): 6333-6345.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/cimb44120432
Vancouver
Melo IB de, Oliveira-Paula GH, Ferezin LP, Ferreira GC, Pinheiro LC, Tanus-Santos JE, Garcia LV, Lacchini R, Garcia WN de P. TRPA1 polymorphisms modify the hypotensive responses to propofol with no change in nitrite or nitrate levels [Internet]. Current Issues in Molecular Biology. 2022 ; 44( 12): 6333-6345.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/cimb44120432
Artigo de periodico
Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability (2021)
Oliveira-Paula, Gustavo Henrique; Coeli-Lacchini, Fernanda Borchers; Ferezin, Letícia Perticarrara; Ferreira, Graziele Cristina ; Pinheiro, Lucas Cezar ; Garcia, Waynice Neiva de Paula ; Garcia, Luis Vicente ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: European Journal of Clinical Pharmacology. Unidades: FMRP, EERP, FCFRP
Assuntos: MEDICAMENTO, POLIMORFISMO, ÓXIDO NÍTRICO, ANESTESIA, PRESSÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo Henrique et al. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European Journal of Clinical Pharmacology, v. 77, n. 6, p. 869-877, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00228-020-03059-9. Acesso em: 14 nov. 2024.
APA
Oliveira-Paula, G. H., Coeli-Lacchini, F. B., Ferezin, L. P., Ferreira, G. C., Pinheiro, L. C., Garcia, W. N. de P., et al. (2021). Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. European Journal of Clinical Pharmacology, 77( 6), 869-877. doi:10.1007/s00228-020-03059-9
NLM
Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, Ferreira GC, Pinheiro LC, Garcia WN de P, Garcia LV, Tanus-Santos JE, Lacchini R. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 869-877.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s00228-020-03059-9
Vancouver
Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, Ferreira GC, Pinheiro LC, Garcia WN de P, Garcia LV, Tanus-Santos JE, Lacchini R. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 869-877.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s00228-020-03059-9
Artigo de periodico
Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study (2021)
Silva, Roberta Fernanda da; Lacchini, Riccardo ; Pinheiro, Lucas Cezar ; Ferezin, Letícia Perticarrara; Tanus-Santos, José Eduardo ; Luizon, Marcelo Rizzatti; Dionísio, Thiago José; Santos, Carlos Ferreira dos ; Reia, Thaís Amanda; Jacomini, André Mourão; Moreno, Ana Maria Guilmo; Zago, Anderson Saranz
Fonte: Clinical and Experimental Hypertension. Unidades: EERP, FMRP, FOB
Assuntos: ENVELHECIMENTO, EXERCÍCIO FÍSICO, HEREDITARIEDADE, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Roberta Fernanda da et al. Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study. Clinical and Experimental Hypertension, v. 43, n. 7, p. 661-670, 2021Tradução . . Disponível em: https://doi.org/10.1080/10641963.2021.1937202. Acesso em: 14 nov. 2024.
APA
Silva, R. F. da, Lacchini, R., Pinheiro, L. C., Ferezin, L. P., Tanus-Santos, J. E., Luizon, M. R., et al. (2021). Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study. Clinical and Experimental Hypertension, 43( 7), 661-670. doi:10.1080/10641963.2021.1937202
NLM
Silva RF da, Lacchini R, Pinheiro LC, Ferezin LP, Tanus-Santos JE, Luizon MR, Dionísio TJ, Santos CF dos, Reia TA, Jacomini AM, Moreno AMG, Zago AS. Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study [Internet]. Clinical and Experimental Hypertension. 2021 ; 43( 7): 661-670.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1080/10641963.2021.1937202
Vancouver
Silva RF da, Lacchini R, Pinheiro LC, Ferezin LP, Tanus-Santos JE, Luizon MR, Dionísio TJ, Santos CF dos, Reia TA, Jacomini AM, Moreno AMG, Zago AS. Association between endothelial nitric oxide synthase and the renin-angiotensin-aldosterone system polymorphisms, blood pressure and training status in normotensive/pre-hypertension and hypertensive older adults: a pilot study [Internet]. Clinical and Experimental Hypertension. 2021 ; 43( 7): 661-670.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1080/10641963.2021.1937202
Artigo de periodico
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)
Pereira, Daniela A.; Sandrim, Valeria C.; Palei, Ana C.; Amaral, Lorena M.; Belo, Vanessa A.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo ; Luizon, Marcelo R.
Fonte: Pharmacogenomics. Unidades: EERP, FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), CITOCINAS, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 14 nov. 2024.
APA
Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006
NLM
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Vancouver
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Artigo de periodico
Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol (2021)
Paula, Gustavo Henrique Oliveira de; Pereira, Daniela A.; Pinheiro, Lucas Cezar ; Ferreira, Graziele Cristina ; Garcia, Waynice Neiva de Paula ; Garcia, Luis Vicente ; Lacchini, Riccardo ; Luizon, Marcelo R.; Tanus-Santos, José Eduardo
Fonte: Basic & Clinical Pharmacology & Toxicology. Unidades: FMRP, EERP
Assuntos: ANESTÉSICOS INTRAVENOSOS, ESTUDOS TRANSVERSAIS, GENÓTIPOS, HAPLOTIPOS, HIPOTENSÃO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULA, Gustavo Henrique Oliveira de et al. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol. Basic & Clinical Pharmacology & Toxicology, v. 130, n. 2, p. 277-287, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13691. Acesso em: 14 nov. 2024.
APA
Paula, G. H. O. de, Pereira, D. A., Pinheiro, L. C., Ferreira, G. C., Garcia, W. N. de P., Garcia, L. V., et al. (2021). Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol. Basic & Clinical Pharmacology & Toxicology, 130( 2), 277-287. doi:10.1111/bcpt.13691
NLM
Paula GHO de, Pereira DA, Pinheiro LC, Ferreira GC, Garcia WN de P, Garcia LV, Lacchini R, Luizon MR, Tanus-Santos JE. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 130( 2): 277-287.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/bcpt.13691
Vancouver
Paula GHO de, Pereira DA, Pinheiro LC, Ferreira GC, Garcia WN de P, Garcia LV, Lacchini R, Luizon MR, Tanus-Santos JE. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 130( 2): 277-287.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1111/bcpt.13691
Artigo de periodico
Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts (2020)
Figaro-Drumond, Fernanda Viana; Pereira, Sherliane Carla ; Menezes, Itiana Castro; Baes, Cristiane Von Werne ; Coeli-Lacchini, Fernanda Borchers ; Oliveira-Paula, Gustavo Henrique; Cleare, Anthony J.; Young, Allan H.; Tanus-Santos, José Eduardo ; Juruena, Mário Francisco Pereira; Lacchini, Riccardo
Fonte: Behavioural Brain Research. Unidades: EERP, FMRP
Assuntos: ANTIDEPRESSIVOS, USOS TERAPÊUTICOS, ESTUDOS DE CASOS E CONTROLES, QUIMIOTERAPIA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, SISTEMA HIPOTÁLAMO-HIPOFISÁRIO, POLIMORFISMO, TENTATIVA DE SUICÍDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIGARO-DRUMOND, Fernanda Viana et al. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research, v. 81, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2019.112343. Acesso em: 14 nov. 2024.
APA
Figaro-Drumond, F. V., Pereira, S. C., Menezes, I. C., Baes, C. V. W., Coeli-Lacchini, F. B., Oliveira-Paula, G. H., et al. (2020). Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research, 81. doi:10.1016/j.bbr.2019.112343
NLM
Figaro-Drumond FV, Pereira SC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MFP, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts [Internet]. Behavioural Brain Research. 2020 ; 81[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bbr.2019.112343
Vancouver
Figaro-Drumond FV, Pereira SC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MFP, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts [Internet]. Behavioural Brain Research. 2020 ; 81[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bbr.2019.112343
Artigo de periodico
Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis (2020)
Valente, Flavia Mariana; Andrade, Days Oliveira de; Cosenso-Martin, Luciana Neves; Cesarino, Cláudia Bernardi; Guimarães, Sérgio Mussi; Guimarães, Victor Beneditti; Lacchini, Riccardo ; Tanus-Santos, José Eduardo ; Yugar-Toledo, Juan Carlos; Vilela-Martin, José Fernando
Fonte: BMC Cardiovascular Disorders. Unidades: EERP, FMRP
Assuntos: METALOPROTEINASES, BIOMARCADORES, CARDIOLOGIA, HIPERTENSÃO, FISIOPATOLOGIA, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENTE, Flavia Mariana et al. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders, v. 20, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12872-020-01412-5. Acesso em: 14 nov. 2024.
APA
Valente, F. M., Andrade, D. O. de, Cosenso-Martin, L. N., Cesarino, C. B., Guimarães, S. M., Guimarães, V. B., et al. (2020). Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders, 20, 1-7. doi:10.1186/s12872-020-01412-5
NLM
Valente FM, Andrade DO de, Cosenso-Martin LN, Cesarino CB, Guimarães SM, Guimarães VB, Lacchini R, Tanus-Santos JE, Yugar-Toledo JC, Vilela-Martin JF. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis [Internet]. BMC Cardiovascular Disorders. 2020 ; 20 1-7.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1186/s12872-020-01412-5
Vancouver
Valente FM, Andrade DO de, Cosenso-Martin LN, Cesarino CB, Guimarães SM, Guimarães VB, Lacchini R, Tanus-Santos JE, Yugar-Toledo JC, Vilela-Martin JF. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis [Internet]. BMC Cardiovascular Disorders. 2020 ; 20 1-7.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1186/s12872-020-01412-5
Artigo de periodico
DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls (2019)
Brites-Anselmi, Guilhermo; Azevedo, Ana Maria Milanez; Miyazaki, Anderson Heiji Lima ; Pinheiro, Lucas Cezar ; Coeli-Lacchini, Fernanda Borchers; Andrade, Murilo Ferreira de; Molina, Carlos Augusto Fernandes ; Tucci Júnior, Silvio; Hirsch, Emilio; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: Nitric Oxide. Unidades: EERP, FMRP
Assuntos: ÓXIDO NÍTRICO, DISFUNÇÃO ERÉTIL, POLIMORFISMO (GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITES-ANSELMI, Guilhermo et al. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls. Nitric Oxide, v. 92, n. 1, p. 11-17, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2019.08.001. Acesso em: 14 nov. 2024.
APA
Brites-Anselmi, G., Azevedo, A. M. M., Miyazaki, A. H. L., Pinheiro, L. C., Coeli-Lacchini, F. B., Andrade, M. F. de, et al. (2019). DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls. Nitric Oxide, 92( 1), 11-17. doi:10.1016/j.niox.2019.08.001
NLM
Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, Andrade MF de, Molina CAF, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls [Internet]. Nitric Oxide. 2019 ; 92( 1): 11-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2019.08.001
Vancouver
Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, Andrade MF de, Molina CAF, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls [Internet]. Nitric Oxide. 2019 ; 92( 1): 11-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2019.08.001
Artigo de periodico
Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia (2019)
Sandrim, Valéria Cristina ; Coeli-Lacchini, Fernanda Borchers ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho
Fonte: Hypertension in Pregnancy. Unidades: FMRP, EERP, FCFRP
Assuntos: POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, v. 38, n. 2, p. 73-77, 2019Tradução . . Disponível em: https://doi.org/10.1080/10641955.2019.1582664. Acesso em: 14 nov. 2024.
APA
Sandrim, V. C., Coeli-Lacchini, F. B., Tanus-Santos, J. E., Lacchini, R., & Cavalli, R. de C. (2019). Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia. Hypertension in Pregnancy, 38( 2), 73-77. doi:10.1080/10641955.2019.1582664
NLM
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1080/10641955.2019.1582664
Vancouver
Sandrim VC, Coeli-Lacchini FB, Tanus-Santos JE, Lacchini R, Cavalli R de C. Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia [Internet]. Hypertension in Pregnancy. 2019 ; 38( 2): 73-77.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1080/10641955.2019.1582664
Artigo de periodico
Pharmacogenomics and hypertension: current insights (2019)
Oliveira-Paula, Gustavo H.; Pereira, Sherliane Carla ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: Pharmacogenomics and Personalized Medicine. Unidades: FMRP, EERP
Assuntos: GENES, HIPERTENSÃO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo H. et al. Pharmacogenomics and hypertension: current insights. Pharmacogenomics and Personalized Medicine, v. 2019, n. 12, p. 341-359, 2019Tradução . . Disponível em: https://doi.org/10.2147/PGPM.S230201. Acesso em: 14 nov. 2024.
APA
Oliveira-Paula, G. H., Pereira, S. C., Tanus-Santos, J. E., & Lacchini, R. (2019). Pharmacogenomics and hypertension: current insights. Pharmacogenomics and Personalized Medicine, 2019( 12), 341-359. doi:10.2147/PGPM.S230201
NLM
Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights [Internet]. Pharmacogenomics and Personalized Medicine. 2019 ; 2019( 12): 341-359.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2147/PGPM.S230201
Vancouver
Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights [Internet]. Pharmacogenomics and Personalized Medicine. 2019 ; 2019( 12): 341-359.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2147/PGPM.S230201
Artigo de periodico
Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults (2018)
Silva, Roberta Fernanda da; Trapé, Átila Alexandre ; Reia, Thaís Amanda; Lacchini, Riccardo ; Oliveira-Paula, Gustavo Henrique; Pinheiro, Lucas Cezar; Tanus-Santos, José Eduardo; Jacomini, André Mourão; Bueno Júnior, Carlos Roberto ; Zago, Anderson Saranz
Fonte: PLOS One. Unidades: EEFERP, EERP, FMRP
Assuntos: PRESSÃO SANGUÍNEA, ÓXIDO NÍTRICO, HAPLOTIPOS, POLIMORFISMO, APTIDÃO FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Roberta Fernanda da et al. Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults. PLOS One, v. 13, n. 10, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0206254. Acesso em: 14 nov. 2024.
APA
Silva, R. F. da, Trapé, Á. A., Reia, T. A., Lacchini, R., Oliveira-Paula, G. H., Pinheiro, L. C., et al. (2018). Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults. PLOS One, 13( 10). doi:10.1371/journal.pone.0206254
NLM
Silva RF da, Trapé ÁA, Reia TA, Lacchini R, Oliveira-Paula GH, Pinheiro LC, Tanus-Santos JE, Jacomini AM, Bueno Júnior CR, Zago AS. Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults [Internet]. PLOS One. 2018 ; 13( 10):[citado 2024 nov. 14 ] Available from: https://doi.org/10.1371/journal.pone.0206254
Vancouver
Silva RF da, Trapé ÁA, Reia TA, Lacchini R, Oliveira-Paula GH, Pinheiro LC, Tanus-Santos JE, Jacomini AM, Bueno Júnior CR, Zago AS. Association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and physical fitness levels with plasma nitrite concentrations and arterial blood pressure values in older adults [Internet]. PLOS One. 2018 ; 13( 10):[citado 2024 nov. 14 ] Available from: https://doi.org/10.1371/journal.pone.0206254
Artigo de periodico
Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil (2018)
Lacchini, Riccardo ; Muniz, Jaqueline Jóice; Nobre, Yuri Túlio D. Andrez; Cologna, Adauto José; Martins, Antonio Carlos Pereira; Tanus-Santos, José Eduardo
Fonte: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Assuntos: POLIMORFISMO, DISFUNÇÃO ERÉTIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACCHINI, Riccardo et al. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, v. 18, n. 2, p. 238-244, 2018Tradução . . Disponível em: https://doi.org/10.1038/tpj.2017.2. Acesso em: 14 nov. 2024.
APA
Lacchini, R., Muniz, J. J., Nobre, Y. T. D. A., Cologna, A. J., Martins, A. C. P., & Tanus-Santos, J. E. (2018). Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, 18( 2), 238-244. doi:10.1038/tpj.2017.2
NLM
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/tpj.2017.2
Vancouver
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/tpj.2017.2
Artigo de periodico
Preliminary study about the relationship between estimated training status and RAS polymorphisms on blood pressure and ACE activity in the elderly (2018)
Silva, Roberta Fernanda da; Lacchini, Riccardo ; Pinheiro, Lucas Cezar; Dionísio, Thiago José; Jacomini, André Mourão; Santos, Jose Eduardo Tanus dos; Amaral, Sandra Lia; Santos, Carlos Ferreira dos; Zago, Anderson Saranz
Fonte: Journal of the Renin-Angiotensin-Aldosterone System. Unidades: EERP, FOB, FMRP
Assuntos: POLIMORFISMO, SISTEMA RENINA-ANGIOTENSINA, PRESSÃO SANGUÍNEA, TREINAMENTO FÍSICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Roberta Fernanda da et al. Preliminary study about the relationship between estimated training status and RAS polymorphisms on blood pressure and ACE activity in the elderly. Journal of the Renin-Angiotensin-Aldosterone System, v. 19, n. Apr./Ju 2018, p. 9 , 2018Tradução . . Disponível em: https://doi.org/10.1177/1470320318782622. Acesso em: 14 nov. 2024.
APA
Silva, R. F. da, Lacchini, R., Pinheiro, L. C., Dionísio, T. J., Jacomini, A. M., Santos, J. E. T. dos, et al. (2018). Preliminary study about the relationship between estimated training status and RAS polymorphisms on blood pressure and ACE activity in the elderly. Journal of the Renin-Angiotensin-Aldosterone System, 19( Apr./Ju 2018), 9 . doi:10.1177/1470320318782622
NLM
Silva RF da, Lacchini R, Pinheiro LC, Dionísio TJ, Jacomini AM, Santos JET dos, Amaral SL, Santos CF dos, Zago AS. Preliminary study about the relationship between estimated training status and RAS polymorphisms on blood pressure and ACE activity in the elderly [Internet]. Journal of the Renin-Angiotensin-Aldosterone System. 2018 ; 19( Apr./Ju 2018): 9 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1177/1470320318782622
Vancouver
Silva RF da, Lacchini R, Pinheiro LC, Dionísio TJ, Jacomini AM, Santos JET dos, Amaral SL, Santos CF dos, Zago AS. Preliminary study about the relationship between estimated training status and RAS polymorphisms on blood pressure and ACE activity in the elderly [Internet]. Journal of the Renin-Angiotensin-Aldosterone System. 2018 ; 19( Apr./Ju 2018): 9 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1177/1470320318782622
Artigo de periodico
Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol (2018)
Oliveira-Paula, Gustavo Henrique; Lacchini, Riccardo ; Pinheiro, Lucas Cezar; Ferreira, Graziele Cristina; Luizon, Marcelo Rizzatti; Garcia, Waynice Neiva de Paula; Garcia, Luis Vicente; Tanus-Santos, José Eduardo
Fonte: Nitric Oxide. Unidades: EERP, FMRP
Assuntos: ANESTESIA ENDOVENOSA, PRESSÃO SANGUÍNEA, HAPLOTIPOS, NITRATOS, ÓXIDO NÍTRICO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo Henrique et al. Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol. Nitric Oxide, v. 75, p. 77-84, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2018.02.007. Acesso em: 14 nov. 2024.
APA
Oliveira-Paula, G. H., Lacchini, R., Pinheiro, L. C., Ferreira, G. C., Luizon, M. R., Garcia, W. N. de P., et al. (2018). Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol. Nitric Oxide, 75, 77-84. doi:10.1016/j.niox.2018.02.007
NLM
Oliveira-Paula GH, Lacchini R, Pinheiro LC, Ferreira GC, Luizon MR, Garcia WN de P, Garcia LV, Tanus-Santos JE. Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol [Internet]. Nitric Oxide. 2018 ; 75 77-84.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2018.02.007
Vancouver
Oliveira-Paula GH, Lacchini R, Pinheiro LC, Ferreira GC, Luizon MR, Garcia WN de P, Garcia LV, Tanus-Santos JE. Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol [Internet]. Nitric Oxide. 2018 ; 75 77-84.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2018.02.007
Artigo de periodico
Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction (2018)
Muniz, Jaqueline Jóice; Leite, Letícia Nogueira; Lacchini, Riccardo ; Tanus-Santos, José Eduardo; Tirapelli, Carlos Renato
Fonte: Canadian Journal of Physiology and Pharmacology. Unidades: EERP, FMRP
Assuntos: ABUSO DE ÁLCOOL, ETANOL, METALOPROTEINASES, MÚSCULO LISO, RNA MENSAGEIRO, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNIZ, Jaqueline Jóice et al. Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction. Canadian Journal of Physiology and Pharmacology, v. 96, n. 3, p. 266-274, 2018Tradução . . Disponível em: https://doi.org/10.1139/cjpp-2017-0082. Acesso em: 14 nov. 2024.
APA
Muniz, J. J., Leite, L. N., Lacchini, R., Tanus-Santos, J. E., & Tirapelli, C. R. (2018). Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction. Canadian Journal of Physiology and Pharmacology, 96( 3), 266-274. doi:10.1139/cjpp-2017-0082
NLM
Muniz JJ, Leite LN, Lacchini R, Tanus-Santos JE, Tirapelli CR. Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction [Internet]. Canadian Journal of Physiology and Pharmacology. 2018 ; 96( 3): 266-274.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1139/cjpp-2017-0082
Vancouver
Muniz JJ, Leite LN, Lacchini R, Tanus-Santos JE, Tirapelli CR. Dysregulated mitogen-activated protein kinase and matrix metalloproteinase in ethanol-induced cavernosal dysfunction [Internet]. Canadian Journal of Physiology and Pharmacology. 2018 ; 96( 3): 266-274.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1139/cjpp-2017-0082
Artigo de periodico
Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production (2018)
Oliveira-Paula, Gustavo Henrique; Pinheiro, Lucas C.; Ferreira, Graziele C.; Garcia, Waynice Neiva de Paula; Lacchini, Riccardo ; Garcia, Luis Vicente; Tanus-Santos, José Eduardo
Fonte: Free Radical Biology and Medicine. Unidades: EERP, FMRP
Assuntos: ANESTESIA, ANGIOTENSINAS, HIPOTENSÃO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo Henrique et al. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production. Free Radical Biology and Medicine, v. 115, p. 10-17, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2017.11.010. Acesso em: 14 nov. 2024.
APA
Oliveira-Paula, G. H., Pinheiro, L. C., Ferreira, G. C., Garcia, W. N. de P., Lacchini, R., Garcia, L. V., & Tanus-Santos, J. E. (2018). Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production. Free Radical Biology and Medicine, 115, 10-17. doi:10.1016/j.freeradbiomed.2017.11.010
NLM
Oliveira-Paula GH, Pinheiro LC, Ferreira GC, Garcia WN de P, Lacchini R, Garcia LV, Tanus-Santos JE. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production [Internet]. Free Radical Biology and Medicine. 2018 ; 115 10-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2017.11.010
Vancouver
Oliveira-Paula GH, Pinheiro LC, Ferreira GC, Garcia WN de P, Lacchini R, Garcia LV, Tanus-Santos JE. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production [Internet]. Free Radical Biology and Medicine. 2018 ; 115 10-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2017.11.010
Artigo de periodico
Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases (2017)
Oliveira-Paula, Gustavo Henrique; Lacchini, Riccardo ; Tanus-Santos, José Eduardo
Fonte: Nitric Oxide. Unidades: EERP, FMRP
Assuntos: ÓXIDO NÍTRICO, POLIMORFISMO, FARMACOGENÉTICA, ENDOTÉLIO VASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo Henrique e LACCHINI, Riccardo e TANUS-SANTOS, José Eduardo. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide, v. 63, p. 39-51, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2016.08.004. Acesso em: 14 nov. 2024.
APA
Oliveira-Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2017). Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide, 63, 39-51. doi:10.1016/j.niox.2016.08.004
NLM
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases [Internet]. Nitric Oxide. 2017 ; 63 39-51.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2016.08.004
Vancouver
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases [Internet]. Nitric Oxide. 2017 ; 63 39-51.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2016.08.004
Artigo de periodico
Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy (2017)
Azevedo, Ana Maria Milanez; Brites-Anselmi, Guilhermo; Pinheiro, Lucas Cezar; Belo, Vanessa de Almeida; Coeli-Lacchini, Fernanda Borchers; Molina, Carlos Augusto Fernandes; Andrade, Murilo Ferreira de; Tucci Júnior, Silvio; Hirsch, Emilio; Tanus-Santos, José Eduardo; Lacchini, Riccardo
Fonte: Nitric Oxide. Unidades: FMRP, EERP
Assuntos: ARGININA, BIOMARCADORES, DISFUNÇÃO ERÉTIL, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Ana Maria Milanez et al. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy. Nitric Oxide, v. 71, p. 44-51, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2017.10.006. Acesso em: 14 nov. 2024.
APA
Azevedo, A. M. M., Brites-Anselmi, G., Pinheiro, L. C., Belo, V. de A., Coeli-Lacchini, F. B., Molina, C. A. F., et al. (2017). Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy. Nitric Oxide, 71, 44-51. doi:10.1016/j.niox.2017.10.006
NLM
Azevedo AMM, Brites-Anselmi G, Pinheiro LC, Belo V de A, Coeli-Lacchini FB, Molina CAF, Andrade MF de, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy [Internet]. Nitric Oxide. 2017 ; 71 44-51.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2017.10.006
Vancouver
Azevedo AMM, Brites-Anselmi G, Pinheiro LC, Belo V de A, Coeli-Lacchini FB, Molina CAF, Andrade MF de, Tucci Júnior S, Hirsch E, Tanus-Santos JE, Lacchini R. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy [Internet]. Nitric Oxide. 2017 ; 71 44-51.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.niox.2017.10.006

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada